HHS releases drug pricing announcements, fails to address harmful DIR fees

Rebate reform 

July’s Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen called on CMS to carry out rulemaking and publicly confirm that “[i]t is the policy of the United States that discounts offered on prescription drugs should be passed on to patients,” so Friday’s final rule was expected.